Verve Therapeutics, Inc.
Industry Group: Commercial Services
Country/Region: United States of America
Identifier: NAS:VERV
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Commercial Services 342 out of 423
Universe
Global Universe 8189 out of 15062
What are the ESG Risk Ratings?
Notice: The information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a credit rating or as a benchmark is not permitted. Unless otherwise explicitly agreed in writing, usage for products and services, index creation, derivative work, portfolio or fund management, or any other usage are not permitted. By way of exception, usage is permitted only to the rated company, limited to a single reference of its own information in annual reporting and sustainability website, mentioning Sustainalytics as a source.
Industry Comparison
| Company | ESG Risk Rating | Industry Rank |
|---|---|---|
| MITIE Group Plc |
12.5
Low
|
67 out of 423 |
| Bilfinger SE |
16.8
Low
|
127 out of 423 |
| KAR Auction Services, Inc. |
18.2
Low
|
149 out of 423 |
| Smart Metering Systems Plc |
26.9
Medium
|
333 out of 423 |
| Verve Therapeutics, Inc. |
27.2
Medium
|
342 out of 423 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.